Health Condition 1: - Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade 1 and 2 patients undergoing breast cancer surgeries
Exclusion criteria
Exclusion criteria: 1.Age less than 18 and greater than 65 years 2.Patients refusal to take part in the study 3.Patients on any of the study drugs prior to the surgery. 4.Weight less than 40 kgs 5.Patients with known hypersensitivity to study drugs 6.Patients having history of drug abuse 7.Patients who are mentally retarded 8.ASA grade 3 and 4 6
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesiaTimepoint: Duration of analgesia from drug administration to VAS equals to or more than 4 in postoperative period in first 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Intraoperative haemodynamic stability 2.Sideffects of study drugs 3.Total dose of postoperative analgesic requirementsTimepoint: 1.Intraoperative haemodynamic stability upto end of surgery 2.In first 24 hours | — |
Countries
India
Contacts
Sri Guru Ram Das Institute Of Medical Sciences And Research